JPRN-UMIN000001407未知未知
The Efficacy and Safety of the new biologic agents (humanized anti-human Interlukin-6 receptor monoclonal antibody) on abnormal lipid metabolism and atherosclerosis for rheumatoid arthritis patients in Japan - The Efficacy and Safety of the new humanized anti-human interlukin-6 reCeptor mOnoclonal antibody on abnormal lipid metabolism and atherosclerosis for Rheumatoid arthritis in Japan (The ESCORT study)
The First Department of Internal Medicine.University of Occupation & Environmental Health0 个研究点目标入组 120 人开始时间: 2008年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •RA patients who have serious infection patients who have history of severe allergic or anaphylactic reactions to human, humanized or murine monoclonal antibodies patients with Primary or secondary immunodeficiency
研究者
相似试验
招募中
Unknown
Evaluation of the Efficacy of Biologics for Asthma in the Real Worldasthmatic patientsJPRN-jRCT1031230202akashima Kei200
招募中
不适用
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed elderly symptomatic multiple myeloma: phase 2 study FBMTG EMM17Multiple myelomaJPRN-UMIN000028421FBMTG49
招募中
不适用
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase 2 studyMultiple myelomaJPRN-UMIN000024165JSCT133
已完成
2 期
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, and consolidation therapy in elderiy patients with newly diagnosed symptomatic multiple myeloma.Multiple myelomaJPRN-UMIN000010166Fukuoka Blood and Marrow Transplantation Group50
已完成
不适用
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase2 studyMultiple myelomaJPRN-UMIN000007216Japan Study Group for Cell Therapy and Transplantation56